1. Home
  2. KNOP vs RIGL Comparison

KNOP vs RIGL Comparison

Compare KNOP & RIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNOP
  • RIGL
  • Stock Information
  • Founded
  • KNOP 2013
  • RIGL 1996
  • Country
  • KNOP United Kingdom
  • RIGL United States
  • Employees
  • KNOP N/A
  • RIGL N/A
  • Industry
  • KNOP Marine Transportation
  • RIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • KNOP Consumer Discretionary
  • RIGL Health Care
  • Exchange
  • KNOP Nasdaq
  • RIGL Nasdaq
  • Market Cap
  • KNOP 235.1M
  • RIGL 247.1M
  • IPO Year
  • KNOP 2013
  • RIGL 2000
  • Fundamental
  • Price
  • KNOP $6.07
  • RIGL $24.10
  • Analyst Decision
  • KNOP
  • RIGL Buy
  • Analyst Count
  • KNOP 0
  • RIGL 5
  • Target Price
  • KNOP N/A
  • RIGL $31.30
  • AVG Volume (30 Days)
  • KNOP 58.4K
  • RIGL 276.8K
  • Earning Date
  • KNOP 12-04-2024
  • RIGL 11-07-2024
  • Dividend Yield
  • KNOP 1.71%
  • RIGL N/A
  • EPS Growth
  • KNOP N/A
  • RIGL N/A
  • EPS
  • KNOP N/A
  • RIGL 0.22
  • Revenue
  • KNOP $296,181,000.00
  • RIGL $157,374,000.00
  • Revenue This Year
  • KNOP $6.70
  • RIGL $38.26
  • Revenue Next Year
  • KNOP $2.79
  • RIGL $24.21
  • P/E Ratio
  • KNOP N/A
  • RIGL $108.84
  • Revenue Growth
  • KNOP 5.27
  • RIGL 21.65
  • 52 Week Low
  • KNOP $4.94
  • RIGL $7.48
  • 52 Week High
  • KNOP $9.11
  • RIGL $29.82
  • Technical
  • Relative Strength Index (RSI)
  • KNOP 43.92
  • RIGL 69.60
  • Support Level
  • KNOP $5.90
  • RIGL $13.91
  • Resistance Level
  • KNOP $6.24
  • RIGL $29.16
  • Average True Range (ATR)
  • KNOP 0.19
  • RIGL 1.98
  • MACD
  • KNOP 0.03
  • RIGL 1.23
  • Stochastic Oscillator
  • KNOP 55.26
  • RIGL 64.80

About KNOP KNOT Offshore Partners LP Common Units representing Limited Partner Interests

KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

Share on Social Networks: